Anant Labs

Erythromycin Ethylsuccinate EP Impurity G

Impureza

Esta molécula é um impureza de Erythromycin.

Erythromycin Ethylsuccinate EP Impurity G
Em Estoque

Impureza

Erythromycin Ethylsuccinate EP Impurity G

Cat. No. ANTPRD513Em EstoqueSintetizado
WhatsAppBaixar MSDS
Dados Técnicos
Cat. No.ANTPRD513
CAS—
Fórmula Mol.C42H73NO16
Peso Mol.848.037 g/mol
IUPACethyl 4-[[(2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-methylamino]-4-oxobutanoate
SMILESCCOC(=O)CCC(=O)N(C)[C@H]1C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)[C@@H]1O
InChIInChI=1S/C42H73NO16/c1-14-28-42(11,52)35(48)23(5)32(46)21(3)19-40(9,51)37(59-39-33(47)27(18-22(4)55-39)43(12)29(44)16-17-30(45)54-15-2)24(6)34(25(7)38(50)57-28)58-31-20-41(10,53-13)36(49)26(8)56-31/h21-28,31,33-37,39,47-49,51-52H,14-20H2,1-13H3/t21-,22-,23+,24+,25-,26+,27+,28-,31+,33-,34+,35-,36+,37-,39+,40-,41-,42-/m1/s1
Chave InChIKQRJURQIAYAVCO-NSTIDYSTSA-N
Descrição

Visão geral

Erythromycin Ethylsuccinate EP Impurity G, Erythromycin, ethyl 4-[[(2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-methylamino]-4-oxobutanoate

A Anant Labs é a renomada e autêntica fabricante e fornecedora de Erythromycin Ethylsuccinate EP Impurity G na Índia.

A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.

Sinônimos

N-Demethyl-N-(ethylsuccinyl) erythromycinErythromycin N-Ethylsuccinate;Erythromycin Ethylsuccinate EP Impurity GErythromycin ethylsuccinate Impurity 52ethyl 4-(((2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-3-hydroxy-6-methylt